199 related articles for article (PubMed ID: 22857012)
1. Probing ligand-binding modes and binding mechanisms of benzoxazole-based amide inhibitors with soluble epoxide hydrolase by molecular docking and molecular dynamics simulation.
Chen H; Zhang Y; Li L; Han JG
J Phys Chem B; 2012 Aug; 116(34):10219-33. PubMed ID: 22857012
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
Karami L; Saboury AA; Rezaee E; Tabatabai SA
Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
[TBL] [Abstract][Full Text] [Related]
3. Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase.
Chen H; Zhang Y; Ye C; Feng TT; Han JG
J Biomol Struct Dyn; 2014; 32(8):1231-47. PubMed ID: 23815795
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening.
Xing L; McDonald JJ; Kolodziej SA; Kurumbail RG; Williams JM; Warren CJ; O'Neal JM; Skepner JE; Roberds SL
J Med Chem; 2011 Mar; 54(5):1211-22. PubMed ID: 21302953
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
Gurung AB; Mayengbam B; Bhattacharjee A
Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
[TBL] [Abstract][Full Text] [Related]
6. A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.
Shen HC; Ding FX; Deng Q; Xu S; Tong X; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Roy S; Zhang B; Tata JR; Berger JP; Colletti SL
Bioorg Med Chem Lett; 2009 Oct; 19(19):5716-21. PubMed ID: 19700315
[TBL] [Abstract][Full Text] [Related]
7. Soluble epoxide hydrolase inhibitory components from Rheum undulatum and in silico approach.
Jo AR; Kim JH; Yan XT; Yang SY; Kim YH
J Enzyme Inhib Med Chem; 2016; 31(sup2):70-78. PubMed ID: 27555350
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Docking Study and Biological Evaluation of Amide-Based Soluble Epoxide Hydrolase Inhibitors with Novel Secondary Pharmacophore of Pyrimidin-2-ol.
Hejazi L; Ebadi A; Fakhar Z; Nazari M; Rezaee E; Abbas Tabatabai S
Chem Biodivers; 2022 Nov; 19(11):e202200231. PubMed ID: 36152343
[TBL] [Abstract][Full Text] [Related]
9. Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe.
Sun YN; Kim JH; Li W; Jo AR; Yan XT; Yang SY; Kim YH
Bioorg Med Chem; 2015 Oct; 23(20):6659-65. PubMed ID: 26372074
[TBL] [Abstract][Full Text] [Related]
10. Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors.
Rezaee E; Amrolah SM; Nazari M; Tabatabai SA
Mol Divers; 2021 Feb; 25(1):45-53. PubMed ID: 31873869
[TBL] [Abstract][Full Text] [Related]
11. Natural soluble epoxide hydrolase inhibitors from Inula britanica and their potential interactions with soluble epoxide hydrolase: Insight from inhibition kinetics and molecular dynamics.
Zhao WY; Yan JJ; Zhang M; Wang C; Feng L; Lv X; Huo XK; Sun CP; Chen LX; Ma XC
Chem Biol Interact; 2021 Aug; 345():109571. PubMed ID: 34217688
[TBL] [Abstract][Full Text] [Related]
12. Natural soluble epoxide hydrolase inhibitors from Alisma orientale and their potential mechanism with soluble epoxide hydrolase.
Zhao WY; Zhang XY; Zhou MR; Tian XG; Lv X; Zhang HL; Deng S; Zhang BJ; Sun CP; Ma XC
Int J Biol Macromol; 2021 Jul; 183():811-817. PubMed ID: 33957203
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.
Kim IH; Park YK; Nishiwaki H; Hammock BD; Nishi K
Bioorg Med Chem; 2015 Nov; 23(22):7199-210. PubMed ID: 26507430
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in silico investigation of anthocyanin derivatives as soluble epoxide hydrolase inhibitors.
Kim JH; Cho IS; Ryu J; Lee JS; Kang JS; Kang SY; Kim YH
Int J Biol Macromol; 2018 Jun; 112():961-967. PubMed ID: 29447963
[TBL] [Abstract][Full Text] [Related]
15. In silico investigation of cycloartane triterpene derivatives from Cimicifuga dahurica (Turcz.) Maxim. roots for the development of potent soluble epoxide hydrolase inhibitors.
Thao NP; Kim JH; Thuy Luyen BT; Dat NT; Kim YH
Int J Biol Macromol; 2017 May; 98():526-534. PubMed ID: 28188798
[TBL] [Abstract][Full Text] [Related]
16. Phytochemical constituents from Scutellaria baicalensis in soluble epoxide hydrolase inhibition: Kinetics and interaction mechanism merged with simulations.
Liu ZB; Sun CP; Xu JX; Morisseau C; Hammock BD; Qiu F
Int J Biol Macromol; 2019 Jul; 133():1187-1193. PubMed ID: 30980876
[TBL] [Abstract][Full Text] [Related]
17. Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids.
Gomez GA; Morisseau C; Hammock BD; Christianson DW
Protein Sci; 2006 Jan; 15(1):58-64. PubMed ID: 16322563
[TBL] [Abstract][Full Text] [Related]
18. Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses.
Appiah-Kubi P; Soliman ME
J Biomol Struct Dyn; 2016 Nov; 34(11):2418-33. PubMed ID: 26555301
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory Activity of Quercetin 3-
Cho IS; Kim JH; Lin Y; Su XD; Kang JS; Yang SY; Kim YH
Molecules; 2020 Sep; 25(18):. PubMed ID: 32972033
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).
Das N; Dhanawat M; Kulshrestha A; Shrivastava SK
Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
